Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 885 entries
View as:

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01110421 Org: User:
Start: 12/31/10 End: 03/31/12 Due: 03/31/13

A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04019041 Org: User:
Start: 09/16/19 End: 11/17/20 Due: 11/17/21

A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02345928 Org: User:
Start: 08/05/14 End: 03/16/17 Due: 03/16/18

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT01795703 Org: User:
Start: 06/30/12 End: 10/31/14 Due: 10/31/15

Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01181050 Org: User:
Start: 08/31/10 End: 04/30/12 Due: 04/30/13

A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02617810 Org: User:
Start: 11/30/15 End: 02/29/16 Due: 02/28/17

A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01400503 Org: User:
Start: 04/01/11 End: 03/01/17 Due: 03/01/18

A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01516047 Org: User:
Start: 01/31/12 End: 09/30/12 Due: 09/30/13

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02217566 Org: User:
Start: 09/23/14 End: 10/26/18 Due: 10/26/19

A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01009086 Org: User:
Start: 12/31/09 End: 05/31/13 Due: 05/31/14

A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications

Phase: N/A Priority: Normal
NCT ID: NCT02830178 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Phase: N/A Priority: Normal
NCT ID: NCT01381900 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13

Pre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumab

Phase: N/A Priority: Normal
NCT ID: NCT04264884 Org: User:
Start: - End: - Due: -

A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435

Phase: N/A Priority: Normal
NCT ID: NCT01799603 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT05242445 Org: User:
Start: 04/19/22 End: 05/09/23 Due: 05/09/24

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

Phase: N/A Priority: Normal
NCT ID: NCT02894905 Org: User:
Start: 09/13/16 End: 08/16/17 Due: 08/16/18

Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling

Phase: N/A Priority: Normal
NCT ID: NCT03795402 Org: User:
Start: 03/15/19 End: 12/06/19 Due: 12/06/20

Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use

Phase: N/A Priority: Normal
NCT ID: NCT04817657 Org: User:
Start: - End: - Due: -

A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02454270 Org: User:
Start: 06/15/15 End: 07/26/18 Due: 07/26/19

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02081495 Org: User:
Start: 08/31/14 End: 11/30/15 Due: 11/30/16

A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03025022 Org: User:
Start: 01/17/17 End: 02/27/17 Due: 02/27/18

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02138422 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16

A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

Phase: N/A Priority: Normal
NCT ID: NCT04002700 Org: User:
Start: 05/06/19 End: 05/31/19 Due: 05/31/20

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Phase: N/A Priority: Normal
NCT ID: NCT04132557 Org: User:
Start: 10/09/19 End: 10/25/19 Due: 10/25/20

An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01662310 Org: User:
Start: 06/30/11 End: 04/30/13 Due: 04/30/14